相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carbapenem-Resistant KPC- and TEM-Producing Escherichia coli ST131 Isolated from a Hospitalized Patient with Urinary Tract Infection: First Isolation in Molise Region, Central Italy, July 2018
Giancarlo Ripabelli et al.
MICROBIAL DRUG RESISTANCE (2020)
Activity of Cefiderocol, Ceftazidime-Avibactam, and Eravacycline against Carbapenem-Resistant Escherichia coli Isolates from the United States and International Sites in Relation to Clonal Background, Resistance Genes, Coresistance, and Region
Brian D. Johnston et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Gene Transmission in the One Health Microbiosphere and the Channels of Antimicrobial Resistance
Fernando Baquero et al.
FRONTIERS IN MICROBIOLOGY (2019)
Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections
Beatriz Suay-Garcia et al.
ANTIBIOTICS-BASEL (2019)
Intestinal co-colonization with different carbapenemase-producing Enterobacterales isolates is not a rare event in an OXA-48 endemic area
Marta Hernandez-Garcia et al.
ECLINICALMEDICINE (2019)
Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe
Irene Merino et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
ClermonTyping: an easy-to-use and accurate in silico method for Escherichia genus strain phylotyping
Johann Beghain et al.
MICROBIAL GENOMICS (2018)
Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
Marla J. Giddins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2018)
Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne blaKPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
Ryan K. Shields et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Successful ceftazidime-avibactam treatment of MDR-KPC-positive Klebsiella pneumoniae infection in a patient with traumatic brain injury A case report
Agnese Gugliandolo et al.
MEDICINE (2017)
Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity
Kirk Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-H30Rx and ST131-H30R1 Strains
Hajime Kanamori et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Resistance to Ceftazidime-Avibactam in Klebsiella pneumoniae Due to Porin Mutations and the Increased Expression of KPC-3
Romney M. Humphries et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Mutations in blaKPC-3 That Confer Ceftazidime-Avibactam Resistance Encode Novel KPC-3 Variants That Function as Extended-Spectrum β-Lactamases
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
plasmidSPAdes: assembling plasmids from whole genome sequencing data
Dmitry Antipov et al.
BIOINFORMATICS (2016)
Ceftazidime-Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia
Gary Wu et al.
CLINICAL INFECTIOUS DISEASES (2016)
Carbapenemase-producing Escherichia coli is becoming more prevalent in Spain mainly because of the polyclonal dissemination of OXA-48
Adriana Ortega et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli et al.
LANCET INFECTIOUS DISEASES (2016)
Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131
Nicole Stoesser et al.
MBIO (2016)
Separate F-Type Plasmids Have Shaped the Evolution of the H30 Subclone of Escherichia coli Sequence Type 131
Timothy J. Johnson et al.
MSPHERE (2016)
Evaluation of the eazyplex® SuperBug CRE system for rapid detection of carbapenemases and ESBLs in clinical Enterobacteriaceae isolates recovered at two Spanish hospitals
Sergio Garcia-Fernandez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Prokka: rapid prokaryotic genome annotation
Torsten Seemann
BIOINFORMATICS (2014)
In vivo multiclonal transfer of bla(KPC-3) from Klebsiella pneumoniae to Escherichia coli in surgery patients
F. Gona et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Escherichia coli ST131, an Intriguing Clonal Group
Marie-Helene Nicolas-Chanoine et al.
CLINICAL MICROBIOLOGY REVIEWS (2014)
Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010
Ritu Banerjee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli
James R. Johnson et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Anton Bankevich et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2012)
Escherichia coli Sequence Type ST131 as the Major Cause of Serious Multidrug-Resistant E. coli Infections in the United States
James R. Johnson et al.
CLINICAL INFECTIOUS DISEASES (2010)
Emergence of blaKPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain
Tania Curiao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Diversity of Escherichia coli Strains Producing Extended-Spectrum β-Lactamases in Spain: Second Nationwide Study
Miguel A. Diaz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004
James R. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene
Thierry Naas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
分享论文
